Since 2018, PrEP4All has led the charge for a federally-funded National PrEP Program, and as the movement has gotten more attention, including calls from the White House to Congress to fund such a program, it is more important now than ever to uplift the voices of PrEP users in key HIV policy discussions. That's why PrEP4All is expanding the groundwork laid with our Summer 2023 #PrEPSaves campaign to launch the #PrEPSaves PrEP Users' Union (P2U).

PrEP4All welcomes the Biden Administration's ongoing commitment to a National PrEP Program for un- and underinsured individuals in America. For the third year, the Administration has called for a 10-year $9.8B investment in equitable PrEP scale up to erase enormous racial, gender, and geographic disparities in PrEP uptake (see page 6 of the HHS Budget in Brief).

In response to an unprecedented proposed $767 million in domestic HIV funding cuts in the House of Representatives, PrEP4All, along with our partners AVAC, HIVMA, PrEP In Black America, NASTAD, the HIV + Hepatitis Policy Institute, The AIDS Institute, AIDS United, NMAC, and several members of the Federal AIDS Policy Partnership launched the #SaveHIVFunding campaign at the United States Conference on HIV/AIDS in Washington DC last Fall. Since then, thousands of advocates and community members, along with over 100 organizations, have joined the fight to demand Congress keep the bipartisan commitment to fund Ending the HIV Epidemic (EHE) activities.

PrEP4All will hold a series of high-level consultations that will advance a strategic conversation on the costs, benefits, and best practices for a National PrEP Program for un- and under-insured individuals in America. The organization will convene key experts and thought leaders to capture the potential value of a National PrEP Program for communities across the United States.

Washington, D.C. - On Monday, a coalition of 39 leading public health groups sent a letter urging the White House Drug Shortage Task Force to prioritize action to end the ongoing shortage of Bicillin L-A. Bicillin L-A is the only approved treatment for syphilis in pregnant women and the preferred treatment for syphilis in adults, infants, and children. Clinics and states have reported being unable to access Bicillin L-A, and Pfizer - the drug's exclusive manufacturer - has reported that they will not resolve the shortage until mid 2024.

July 28, 2023 - Soundly rejecting House efforts to gut HIV funding, yesterday the Senate Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations Subcommittee released its FY24 spending bill which clearly reflects concerted efforts by PrEP activists over the past few months to prioritize support for a national PrEP program. The Senate bill would allocate $616 million in funding for the Ending the HIV Epidemic (EHE), including a $3 million increase to CDC that specifically "support[s] the building blocks for a national program to increase…PrEP (pg. 60)."

PrEP4All is proud to announce that our work to ensure equitable PrEP access for all in the United States will be supported by a two-year investment totaling nearly $670,000 from the Elton John AIDS Foundation. This new strategic partnership comes at a pivotal point in the movement for a National PrEP Program for uninsured and underinsured individuals in the United States. PrEP4All, a nonprofit dedicated to equitable PrEP access, was the first organization to call for such a program shortly after its foundation in 2018.

PrEP4All commends the Department of Justice (DOJ) for taking action and urging a Delaware federal judge to overturn the recent verdict in US v. Gilead, which, should it stand, would let Gilead off the hook for infringing on patents held by the federal government. On May 17th, PrEP4All along with the Public Interest Patent Law Institute (PIPLI) and with legal representatives from Columbia Law School's Science, Health, and Information Clinic released a statement expressing extreme disappointment in the verdict in U.S. v. Gilead and calling on DOJ to continue to press its case and potentially call for a new trial.

Calling all public health and sexual health activists! Please join PrEP4All, PrEP In Black America, Treatment Action Group, and AVAC on Tuesday, June 20, 2023, for a webinar on mpox. We'll cover the latest research and updates on how vaccines and treatments work, risk factors for severe symptoms and disease, and the ongoing fight to address disparities in infection rates and uptake of vaccines, treatments and tests that impact Black communities.

Thursday, April 6th, 2023, New York, NY- Hundreds of HIV prevention advocates nationwide convened on Tuesday to discuss the implications of Judge Reed O'Connor's ruling in the Texas Braidwood v. Becerra case that could impact access to PrEP and other preventive health interventions for millions of Americans. The ruling states private insurers are no longer required to cover certain preventive care services under the Affordable Care Act, including PrEP.

New York, NY - April 18, 2023 - The Biden Administration's "Project Next Gen" initiative for new pandemic-focused vaccines and treatments could be delayed by months or even years by pharmaceutical companies that will not make current SARS CoV-2 vaccines readily available for pre-clinical and clinical research, according to PrEP4All. This is the conclusion from the advocacy organization's new report, released today, titled "Science Held Hostage: How Pharma is Using mRNA Vaccine Contracts With Government to Delay Future Innovation." The publication details how pharmaceutical companies are using language from contracts inked in the earliest days of the pandemic as an excuse for delaying access to their vaccines. The report also reveals that US government funding is being used to purchase generic versions of Pfizer's mRNA vaccine for use in pre-clinical research.

Wilmington, DE - March 28, 2023 - On March 20, Judge Maryellen Noreika, presiding judge in the landmark patent infringement case United States v. Gilead Sciences, called for a hearing to review both the U.S. government and Gilead Sciences' reasons for excessive secrecy in their public case filings. The hearing will take place on April 4. This move follows a March 14 letter sent to the judge by Columbia Law School's Science, Health & Information Clinic on behalf of PrEP4All and the Public Interest Patent Law Institute (PIPLI), which flagged pervasive and unjustified redactions by Gilead and the U.S. government alike, requested justification for the parties' secrecy, and requested submission of new, less heavily redacted versions of their filings. Judge Noreika's call for a hearing marks a win for PrEP4All, PIPLI, and public interest and transparency advocates more broadly, as it indicates that she is concerned that the U.S. government and Gilead have improperly shielded much of their evidence and legal arguments from public view. PIPLI and PrEP4All applaud the Judge's rapid response to their letter calling for transparency.

(New York, NY) As part of his FY24 Budget Request released last week, President Biden once again included a $9.8B ten-year proposal for a National PrEP Program. PrEP4All reiterates its gratitude for this vision for a robust PrEP program, which was first proposed last year, and appreciates the Administration's ongoing commitment to establish a National PrEP Program. As we approach 11 years since FDA approval of PrEP, advocates urge the White House to move forward as soon as possible to put in place a national PrEP initiative using discretionary funding to more quickly increase PrEP equity and end current disparities based on race, ethnicity, gender and geography. Increased PrEP access and uptake also would improve health outcomes and reduce health care costs.

PrEP4All and the HIV advocacy community are outraged at U.S. District Judge Reed O'Connor's decision in Braidwood v. Becerra, striking the requirement that most insurers cover a range of critical preventive services such as PrEP, HIV testing, STD screening, cancer screenings, diabetes screenings, and more . PrEP4All, joined by AVAC, HIV Medicine Association, Center for HIV Law & Policy, Lambda Legal, and other HIV prevention advocates, will host an emergency virtual town hall on Tuesday, April 4, 2023 at 6:00 PM ET. We will help the community better understand the implications of Judge Reed's ruling and discuss next advocacy steps to ensure those in need of PrEP can access it.

Join Black HIV prevention advocates from across the U.S. for the second interactive PrEP In Black America Summit in New Orleans, LA on May 19, as we develop and build on existing strategies to increase PrEP access and awareness in the Black community. Thanks to continued support from The Red Hot Organization, we are able to offer the PrEP In Black America Summit at no cost to advocates and community members. 

Atlanta, GA-On National Black HIV/AIDS Awareness Day (Feb. 7), Black HIV Prevention advocates released "For Us By Us: PrEP In Black America: A Master Plan for HIV Prevention In Black America", a roadmap to drastically scale-up use of pre-exposure prophylaxis (PrEP) in the Black community. PrEP is a biomedical tool used to reduce the risk of acquiring HIV by over 99%. The report, which covers findings from the PrEP In Black America Summit held in Atlanta, GA on September 13, 2022, was compiled by researchers in the iSTRIVE Lab, with evaluation data compiled by Muse Research, LLC.

New York, NY - February 27, 2023 - In a new Perspectives article, "Investing In National HIV PrEP Preparedness ," published on February 25th in the New England Journal of Medicine, PrEP4All's Acting Executive Director Jeremiah Johnson and former Managing Director of Advocacy & Organizing Kenyon Farrow along with Amy Killelea of Killelea Consulting and Johns Hopkins University make the case for the Biden Administration, Congress, and the Centers for Disease Control and Prevention (CDC) to immediately advance a National PrEP Program as part of a broader effort to improve public health responses for marginalized communities.

Just two months after the ten-year anniversary of Food and Drug Administration approval of PrEP, Black advocates gathered in Atlanta, GA at our inaugural PrEP in Black America Summit to address the dismal PrEP utilization rates in the Black community. On National Black HIV/AIDS Awareness Day, we will gather again at our "The Power of PrEP" webinar to discuss the outcomes of the Summit and preview a roadmap that will serve as a framework to increase PrEP uptake in the Black community and help end the HIV epidemic